All Industries

Top Biotech Companies

7,732 Biotech companies, sorted by total funding raised.

Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
HugelIPO

South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...

Chuncheon, South Korea201–500Biotech, Healthcare
Private EquityTotal funding$831.0MJun 2017
TheranosClosed

Blood testing technology company claiming miniaturized diagnostics

Palo Alto, United States501–1000Biotech, Healthcare
Venture RoundTotal funding$830.9MJun 2014
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
Parabilis MedicinesIPO

Parabilis develops Helicon peptide therapeutics that modulate intracellular proteins, pursuing bi...

Cambridge, United States201–500Biotech, Life Sciences
Series FTotal funding$812.0MJan 2026
Spiber

Spiber develops Brewed Protein materials, using microbial fermentation to create plant-based fibe...

Tokyo, Japan201–500Biotech, Manufacturing
Venture RoundTotal funding$807.6MDec 2024
FogPharma

Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...

Cambridge, United States51–200Biotech, Drug Discovery
Series FTotal funding$801.0MJan 2025
Mirum PharmaceuticalsIPO

Mirum Pharmaceuticals, Inc. is a clinical-stage therapeutics company developing a novel approach ...

Foster City, United States201–500Biotech, Healthcare
ConvertibleTotal funding$788.5MMay 2026
Perfect Day

Sustainable dairy protein from precision fermentation

Berkeley, United States51–200Biotech
Series ETotal funding$787.7MJan 2024
XtalPiIPO

AI and quantum physics-powered drug discovery platform accelerating pharmaceutical R&D through cr...

Beijing, China1001–5000Biotech, Artificial Intelligence
Series DTotal funding$785.1MJan 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series DTotal funding$760.0MSep 2025
CRISPRIPO

A Basel, Switzerland and Boston, MA-based biopharmaceutical company created to translate CRISPR-C...

Zug, Switzerland201–500Biotech, Healthcare
Venture RoundTotal funding$746.5MFeb 2024
Innovent BioIPO

Innovent Biologics develops, manufactures, and commercializes high-quality innovative medicines s...

Suzhou, China5001–10000Biotech, Healthcare
Venture RoundTotal funding$740.0MJan 2025
NewLimit

NewLimit develops medicines that unlock cellular regenerative potential to extend human healthspa...

South San Francisco, United States11–50Biotech, Healthcare
Venture RoundTotal funding$735.0MJun 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
Beeline Medicines

Beeline Medicines is a clinical-stage biotechnology company developing precision therapies for pe...

Boston, United States11–50Biotech, Healthcare
Series ATotal funding$726.3MJul 2026
EQRxAcquired

Developing new medicines with the goal of expanding global access for patients

Cambridge, United States51–200Healthcare, Biotech
Series BTotal funding$700.0MJan 2021
Odyssey TherapeuticsIPO

Odyssey Therapeutics develops small-molecule and protein medicines that target upstream inflammat...

Boston, United States51–200Biotech, Healthcare
Series DTotal funding$700.0MSep 2025
Solugen

Solugen manufactures lower-carbon specialty chemicals using its Bioforge platform, combining enzy...

Houston, United States51–200Biotech, Climate Tech
Venture RoundTotal funding$695.7MMar 2026
ImmunicIPO

Late-stage biotechnology company developing novel selective oral immunology therapies for chronic...

New York, United StatesBiotech, Healthcare
Private EquityTotal funding$694.9MFeb 2026
Generate BiomedicinesIPO

Generate Biomedicines uses machine learning and large-scale biological experimentation to design ...

Cambridge, United States201–500Artificial Intelligence, Biotech
Corporate RoundTotal funding$693.0MDec 2024
Kriya Therapeutics

Kriya integrates product engineering, analytics, and manufacturing to develop scalable gene thera...

Research Triangle Park, United StatesBiotech, Healthcare
Series DTotal funding$655.0MSep 2025
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026